An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Jyoti Wadhwa ( Moderator ) ,Dr Atul Sharma ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Srujna Joga ( Expert Panel )

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Srujna Joga ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Atul Sharma ( Expert Panel ) ,Dr Jyoti Wadhwa ( Moderator )

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Srujna Joga ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Atul Sharma ( Expert Panel ) ,Dr Jyoti Wadhwa ( Moderator )

Efficient Management of First line ALK-rearranged NSCLC

In this webinar, a detailed discussion is done on the efficient management of first line ALK rearranged NSCLC.

Speakers : Dr B K ,Dr Abhishek Kakroo ,Dr Jogamaya Pattnaik

Efficient Management of First line ALK-rearranged NSCLC - Part V

Explore optimal first-line strategies for ALK-rearranged NSCLC to enhance survival and manage resistance.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti

Efficient Management of First line ALK-rearranged NSCLC - Part IV

Explore optimal first-line strategies and targeted therapies for managing ALK-rearranged non-small cell lung cancer.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti

Efficient Management of First line ALK-rearranged NSCLC - Part III

Explore optimal first-line strategies for managing ALK-rearranged NSCLC with advanced targeted therapies and clinical insights.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti

Efficient Management of First line ALK-rearranged NSCLC - Part II

Discover effective first-line strategies for managing ALK-rearranged NSCLC using targeted therapies and personalized treatment approaches.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti

Efficient Management of First line ALK-rearranged NSCLC - Part VI

In this webinar, a detailed discussion is done on the efficient management of first line ALK rearranged NSCLC.

Speakers : Dr Jogamaya Pattnaik

Efficient Management of First line ALK-rearranged NSCLC - Part VII

Explore first-line management strategies and targeted therapies for ALK-rearranged NSCLC to optimize patient outcomes.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti


Recommended News For You

Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women

Words matter to people living with cancer. Here's how verbal microaggressions affect their mental state

Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

The Higher the Disability Burden From Disease, the Higher the Suicide Risk

AI tool accurately detects tumor location on breast MRI

Cancer detection recovered following pandemic disruptions

Recommended Articles For You

Case Study: The Role of JAK Inhibitors in Myeloproliferative Disorders 

The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease  

Unveiling the Mystery Behind Lymphovascular Invasion 

Molecular & Genetic Oncology: Emerging Frontiers in 2025 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

2.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

3.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

4.

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

5.

Two medications might work better for breast cancers that are resistant to one.

1.

A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology

2.

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease 

3.

Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes

4.

Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies

5.

Exploring the Mysteries of Myxoma: A New Frontier in Medical Research

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

2.

Thromboprophylaxis In Medical Settings

3.

Oropharyngeal Cancer in Relation to HPV Status

4.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

5.

Navigating the Complexities of Ph Negative ALL - Part XV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot